Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 3:57 AM
Ignite Modification Date: 2025-12-25 @ 3:57 AM
NCT ID: NCT02448602
Eligibility Criteria: Inclusion Criteria: * Clinical diagnosis of Insomnia 's Disease; * Aged 18-60 (including 18 and 60); * Does not attend other clinical researchers; * Participation in the researchers signed informed consent and voluntary; * Pittsburgh sleep index (PSQI) index \> 7 points; * Athens scale or 6 points; * Depression scale and anxiety scale 50 points or less. Exclusion Criteria: * Breathing-Related Sleep disorder; * Circadian rhythm disorders; * Sleep disorders; * Drug-induced insomnia (such as drug abuse, drug treatment); * Sleep disorders caused by poor diet, lifestyle factors(Long-term excessive drinking, coffee, tea, etc.); * All systemic diseases (such as pain, fever, cough, surgery, etc.) and the external environment disturbance factors; * With cardiovascular, lung, liver, kidney and hematopoietic system such as serious primary diseases; * Patients with mental illness; * Pregnancy or breast-feeding women; * Acupoints with severe skin infections; * Patients who are afraid of acupuncture; * Advanced malignant tumor or other serious wasting disease, infection and bleeding; * Who do not meet the inclusion criteria, poor compliance, treatment, not according to stipulations can not judge the curative effect or data not congruent affect curative effect and safety of judgment; * Caused by excessive anxiety and depression of patients with insomnia.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 60 Years
Study: NCT02448602
Study Brief:
Protocol Section: NCT02448602